- Home
- ONCY vs DMA Comparison
ONCY vs DMA Comparison
Compare ONCY & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- DMA
- Stock Information
- Founded
- ONCY 1998
- DMA 2011
- Country
- ONCY Canada
- DMA United States
- Employees
- ONCY N/A
- DMA N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- DMA Trusts Except Educational Religious and Charitable
- Sector
- ONCY Health Care
- DMA Finance
- Exchange
- ONCY Nasdaq
- DMA Nasdaq
- Market Cap
- ONCY 86.1M
- DMA 78.6M
- IPO Year
- ONCY 1999
- DMA N/A
- Fundamental
- Price
- ONCY $0.98
- DMA $8.78
- Analyst Decision
- ONCY Strong Buy
- DMA
- Analyst Count
- ONCY 2
- DMA 0
- Target Price
- ONCY $4.00
- DMA N/A
- AVG Volume (30 Days)
- ONCY 386.7K
- DMA 34.6K
- Earning Date
- ONCY 11-12-2024
- DMA 01-01-0001
- Dividend Yield
- ONCY N/A
- DMA 2.04%
- EPS Growth
- ONCY N/A
- DMA N/A
- EPS
- ONCY N/A
- DMA N/A
- Revenue
- ONCY N/A
- DMA N/A
- Revenue This Year
- ONCY N/A
- DMA N/A
- Revenue Next Year
- ONCY N/A
- DMA N/A
- P/E Ratio
- ONCY N/A
- DMA N/A
- Revenue Growth
- ONCY N/A
- DMA N/A
- 52 Week Low
- ONCY $0.84
- DMA $4.78
- 52 Week High
- ONCY $1.75
- DMA $8.00
- Technical
- Relative Strength Index (RSI)
- ONCY 36.89
- DMA 50.21
- Support Level
- ONCY $1.01
- DMA $8.84
- Resistance Level
- ONCY $1.15
- DMA $9.00
- Average True Range (ATR)
- ONCY 0.06
- DMA 0.13
- MACD
- ONCY -0.03
- DMA 0.00
- Stochastic Oscillator
- ONCY 3.14
- DMA 52.17
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.